SCHEDULE: Southpoint Funds Disclose 5% Passive Stake in Dentsply Sirona

Southpoint Master Fund and affiliated entities have reported a 5.0% passive ownership stake in Dentsply Sirona Inc., holding 10 million shares.

Summary

• Southpoint Master Fund, LP, along with Southpoint Capital Advisors LP, Southpoint Capital Advisors LLC, Southpoint GP, LP, Southpoint GP, LLC, and John S. Clark II (collectively, the Reporting Persons), have filed a Schedule 13G.
• The Reporting Persons collectively beneficially own 10,000,000 shares of Dentsply Sirona Inc. Common Stock.
• This ownership represents 5.0% of the Issuer's outstanding Common Stock.
• The ownership percentage is based on 199,749,333 outstanding shares of Common Stock as of February 20, 2026, as reported in Dentsply Sirona Inc.'s Annual Report on Form 10-K filed on February 26, 2026.
• The Reporting Persons have shared voting power and shared dispositive power over all 10,000,000 shares.
• The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it signals significant institutional confidence in Dentsply Sirona Inc. without indicating any immediate disruptive intent from the investor.

Positives

• A significant institutional investor, Southpoint Master Fund and its affiliates, has taken a 5.0% passive stake in Dentsply Sirona Inc., potentially signaling confidence in the company's long-term prospects.
• The passive nature of the investment, as certified by the Reporting Persons, suggests no immediate intent to influence or change the control of the issuer, which can provide stability.

Negatives

• No direct negatives for Dentsply Sirona Inc. are disclosed in this beneficial ownership report.

Risks

• The Reporting Persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11. This mitigates the risk of an immediate activist campaign but leaves open the possibility of future engagement regarding board nominations.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance from Dentsply Sirona Inc. or the Reporting Persons regarding the issuer's future performance.

Industry Context

StockSavvy.ai notes that a 5.0% passive stake by a prominent investment fund like Southpoint in a leading dental technology company such as Dentsply Sirona Inc. indicates continued institutional interest in the healthcare and dental sectors. Such investments often reflect a belief in the company's market position, innovation, or long-term growth potential within its industry.

Comparison to Industry Standards

• This filing is a disclosure of beneficial ownership and does not contain performance metrics or operational results that can be directly compared to industry standards or specific comparable companies. It primarily reflects an investment decision by Southpoint Master Fund and its affiliates.

Stakeholder Impact

• Shareholders may view the entry of a significant institutional investor as a positive signal, potentially bolstering confidence in the company's stock.
• The company's management and board may perceive this as a vote of confidence in their strategy, given the passive nature of the stake.

Key Dates

Recommendation

A 'hold' recommendation is appropriate as the filing indicates a significant, passive institutional investment in Dentsply Sirona Inc. This suggests a long-term positive view from a sophisticated investor, but the filing itself does not provide new operational or financial data to warrant an immediate 'buy' or 'sell' action. It primarily confirms a substantial ownership position.

Keywords

Dentsply Sirona, Southpoint Master Fund, beneficial ownership, Schedule 13G, passive investment, dental technology, common stock, institutional investor